Avivo is proud to announce a publication in Nature Communications demonstrating blood type conversion of human kidneys using Avivo’s enzyme system. The study was performed in collaboration with researchers from the University of Cambridge. Members of the Avivo team were co-authors on the publication:
- Peter Rahfeld, Chief Scientific Officer
- Spencer Macdonald, Vice President, Product Development
- Jayachandran Kizzhakedathu, Board Director & Scientifc Advisor
- Stephen G. Withers, Board Director & Scientific Advisor